Mehmet İNCİ, Bahadır ŞARLI, Ahmet ÇELİK, Abdullah DEMİRTAŞ, Numan BAYDİLLİ, Mahmut AKPEK, Mehmet Güngör KAYA

Relationship between urolithiasis and diastolic functions of the heart

Relationships between urolithiasis and cardiovascular disorders were evaluated in several studies. In this study, we aimed to investigate whether urolithiasis causes a decline in cardiac diastolic functions. Materials and methods: Seventy-seven consecutive patients and 40 age- and sex-matched controls were included in this study. Transthoracic echocardiography was performed for all patients. Results: There were 77 patients (mean age: 45 ± 14 years, 64% male) in the stone-formers group and 40 patients (mean age: 43 ± 12 years, 63% male) in the control group. Peak E wave velocity (0.67 ± 0.21 to 0.85 ± 0.18, P = 0.001) and E/A ratio (0.97 ± 0.21 to 1.37 ± 0.27, P = 0.001) were significantly lower in stone formers than in control patients. In addition, peak A wave velocity (0.74 ± 0.15 to 0.69 ± 0.14) was significantly higher in stone formers than control patients (P = 0.01). Diastolic dysfunction was more frequent in stone formers than control patients (P = 0.015). Conclusion: This study shows that there is a link between urolithiasis and cardiac diastolic dysfunction. Urolithiasis should therefore be recognized in evaluation of patients with diastolic dysfunction.

Anahtar Kelimeler:

Key words: Urinary system, urolithiasis, diastolic dysfunction

Relationship between urolithiasis and diastolic functions of the heart

Keywords:

Key words: Urinary system, urolithiasis, diastolic dysfunction,

PDF

___

Buchholz NP, Abbas F, Afzal M, Khan R, Rizvi I, Talati J. The prevalence of silent kidney stones--an ultrasonographic screening study. J Pak Med Assoc 2003; 53: 24–5.
Yapanoğlu T, Demirel A, Adanur Ş, Yüksel H, Polat Ö. X-ray diffraction analysis of urinary tract stones. Turk J Med Sci 2010; 40: 415–20.
Aydin H, Yencilek F, Erihan IB, Okan B, Sarica K. Increased 10-year cardiovascular disease and mortality risk scores in asymptomatic patients with calcium oxalate urolithiasis. Urol Res 2011; 39: 451–8.
Hamano S, Nakatsu H, Suzuki N, Tomioka S, Tanaka M, Murakami S. Kidney stone disease and risk factors for coronary heart disease. Int J Urol 2005; 12: 859–63.
Losito A, Nunzi EG, Covarelli C, Nunzi E, Ferrara G. Increased acid excretion in kidney stone formers with essential hypertension. Nephrol Dial Transplant 2009; 24: 137–41.
Yalçın F, Thomas J. Diastolic dysfunction: pathogenesis, therapy and the importance of Doppler echocardiography. Turk J Med Sci 1999; 29: 501–5.
Kibar M, Markovic M, Kolm US, Thalhammer J. Determination of diastolic dysfunction by conventional and Doppler tissue echocardiography in dogs. Turk J Vet Anim Sci 2009; 33: 501–7.
Badano LP, Albanese MC, De Biaggio P, Rozbowsky P, Miani D, Fresco C et al. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction. J Am Soc Echocardiogr 2004; 17: 253–61.
Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999; 33: 1948–55.
Cohn JN, Johnson G. Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group. Circulation 1990; 81: III48–53.
Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194–202.
Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 19 Circulation 1998; 98: 2282–9.
Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol 2001; 87: 413–9.
Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000; 35: 1628–37.
Devereux RB, Roman MJ, Liu JE, Welty TK, Lee ET, Rodeheffer R et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol 2000; 86: 1090–6.
Cowie MR, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Suresh V et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J 1999; 20: 421–8.
O’Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994; 13: S107–12.
Hale CS. Diastolic dysfunction: prevalence, mortality risk, and assessing severity to stratify risk. J Insur Med 2009; 41: 254–63.
Çiçekçioğlu H, Ergün İ, Uçar O, Yüksel C, Azak A, Abaylı E et al. Cardiac complications of secondary hyperparathyroidism in chronic hemodialysis patients. Turk J Med Sci 2011; 41: 789–94.
Shackebaei DA, Asadmobin AT, Hesari MA, Vaezi MA, Shahidi S. Cardioprotective effect of diazepam on ischemia-reperfused isolated hyperthyroid rat heart. Turk J Biol 2012; 36: 598–605.
Madore F, Stampfer MJ, Rimm EB, Curhan GC. Nephrolithiasis and risk of hypertension. Am J Hypertens 1998; 11: 46–53.
Strazzullo P, Barba G, Vuotto P, Farinaro E, Siani A, Nunziata V et al. Past history of nephrolithiasis and incidence of hypertension in men: a reappraisal based on the results of the Olivetti Prospective Heart Study. Nephrol Dial Transplant 2001; 16: 2232–5.
Rule AD, Krambeck AE, Lieske JC. Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol 2011; 6: 2069–75.
Binbay M, Yuruk E, Akman T, Sari E, Yazici O, Ugurlu IM et al. Updated epidemiologic study of urolithiasis in Turkey II: role of metabolic syndrome components on urolithiasis. Urol Res 2012; 40: 247–52.
Yasui T, Itoh Y, Bing G, Okada A, Tozawa K, Kohri K. Aortic calcification in urolithiasis patients. Scand J Urol Nephrol 2007; 41: 419–21.
Celik A, Davutoglu V, Sarica K, Erturhan S, Ozer O, Sari I et al. Relationship between renal stone formation, mitral annular calcification and bone resorption markers. Ann Saudi Med 2010; 30: 301–5.
Rule AD, Roger VL, Melton LJ 3rd, Bergstralh EJ, Li X, Peyser PA et al. Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol 2010; 21: 1641–4.
Ramey SL, Franke WD, Shelley MC 2nd. Relationship among risk factors for nephrolithiasis, cardiovascular disease, and ethnicity: focus on a law enforcement cohort. AAOHN J 2004; 52: 116–21.
Hamano S, Nakatsu H, Suzuki N, Tomioka S, Tanaka M, Murakami S. Kidney stone disease and risk factors for coronary heart disease. Int J Urol 2005; 12: 859–63.
Schlieper G, Westenfeld R, Brandenburg V, Ketteler M. Inhibitors of calcification in blood and urine. Semin Dial 2007; 20: 113–21.